The Ifakara Ambient Chamber Test (I-ACT) for Evaluation of Indoor Residual Sprays: A Non-Inferiority Test of Sylando® 240SC and SumiShield® 50WG
Year: 2026
Type: article
Abstract: New insecticides for indoor residual spraying (IRS) are being developed to manage resistance. Chlorfenapyr (Sylando® 240SC), a pro-insecticide, is metabolised by active mosquitoes into the toxic metabolite tralopyril. This mode of action requires adapted “free flying” bioassays. A miniature-experimental hut (MEH) assay was developed within the Ifakara Ambient Chamber Test (I-ACT) with a rabbit blood host to measure residual efficacy under controlled conditions. Sylando® 240SC was compared with SumiShield® 50WG (clothianidin) for 12-month residual efficacy against malaria and arbovirus vectors. Residual activity was assessed on mud, wood and concrete with two huts per substrate treated with Sylando® 240SC, one with SumiShield® 50WG, and one untreated control. Five replicates of 20 mosquitoes per strain (malaria vectors: pyrethroid-susceptible Anopheles gambiae, resistant An. arabiensis and An. funestus; culicines Aedes aegypti and Culex quinquefasciatus) were exposed overnight at one-week post-spraying and monthly thereafter. Multivariable mixed-effects logistic regression assessed non-inferiority with a 7% margin. Both products induced delayed mortality, with higher effects on malaria vectors than culicines. Across all substrates and malaria species combined over the full 12 months of observation, Sylando® 240SC was non-inferior to SumiShield® 50WG at 72 h (76% vs. 67%, OR=0.86, 95% CI: 0.77–0.97) and 168 h (89% vs. 82%, OR=0.74, 95% CI: 0.63–0.87). Sylando® 240SC performed comparably to SumiShield® 50WG, supporting its use as an IRS option. The new I-ACT mini-experimental-hut assay provides a practical tool for evaluating pro-insecticides. The importance of free flight evaluation methods for pro-insecticides is discussed.
Source: Insects
Authors: Jane Johnson Machange, Ahmadi B. Mpelepele, Frank S.C Tenywa, Mzee Pwagu, Dickson Kobe, Saphina H. Ngonyani, Dismas S. Kamande, Isaya Matanila, Ibrahim Kibwengo, Jason Moore, Joseph B. Muganga, Ritha Rex Kidyala, Prisca A. Kweyamba, Sussane Stutz, James W. Austin, Sarah Jane Moore, Ummi Abdul Kibondo
Institutions: Ifakara Health Institute, BASF (Germany), BASF (United States)
Language: English
Topic: Malaria Research and Control
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,137
OpenAlex ID: W7135011697
